retatrutide clinical trials weight loss retatrutide A New Obesity Drug Delivered Surgery-Level in Eli Lilly's Phase 3 clinical

It promotes the proliferation & differentiation of satellite cells into mature myofibers, leading to increased muscle mass & strength

GLP-1s work by regulating appetite and supporting metabolic health

Vomiting occurs in roughly 25% of participants

It links degradation to reduced appetite suppression, diminished weight loss outcomes, and inconsistent glucose control

When food remains in the stomach for extended periods of time, patients may develop severe nausea, vomiting, dehydration, malnutrition, abdominal swelling, and painful digestive complications requiring hospitalization or emergency treatment

If youre thinking that youre partially correct, but theres a crucial nuance here